The Amount of Plasminogen, Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 in Human Thrombi and the Relation to IVVO-TNO Lysibility
- 1 January 1992
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 67 (01) , 101-105
- https://doi.org/10.1055/s-0038-1648388
Abstract
Summary: Thrombolytic therapy successfully reopens obstructed blood vessels in the majority of cases. However, it is not known why a substantial amount of thrombi are resistant to lysis by a fibrinolytic agent. In vitro studies have demonstrated that tissue-type plasminogen activator (t-PA) and plasminogen incorporated in the clot (during formation) increase lysibility. To test whether lysibility of in vivo formed human thrombi is related to their composition, we studied 25 venous thrombi obtained at autopsy and 21 arterial thrombi obtained during embolectomy.Plasminogen activator inhibitor-1 (PAI-1) antigen was measured in a phosphate-buffered saline (PBS) extract of each thrombus; t-PA antigen and plasminogen antigen were determined in a 6 M urea extract of the thrombus, representing bound proteins. Lysibility was measured as weight reduction during 8 h of incubation in PBS containing streptokinase (SK) 100 U/ml, corrected for spontaneous lysis, reflected by weight loss in PBS without SK. In addition, lysibility in SK was compared with lysibility in urokinase (UK) 100 U/ml and in t-PA 200 U/ml.Spontaneous lysis amounted to 29 ± 5% (mean ± SEM) and 33 ± 5% in venous and arterial thrombi, respectively, and inversely correlated with the PAI-1 content of thrombi (r = —0.43, p <0.01). Lysibility amounted to 76 ± 6% in venous and 90 ± 4% in arterial thrombi (venous vs. arterial: p = 0.051). PAI-1-, plasminogen- and t-PA-content of venous thrombi were 902 ± 129 ng, 34.3 ± 4.8 pg and 26.7 ± 3.0 ng per gram of wet thrombus respectively; for arterial thrombi these values were 2,031 ± 401 ng/g (p = 0.011), 64.1 ± 11.4 pg/g (p = 0.088) and 62.2 ± 8.3 ng/g (p = 0.0001), respectively. A correlation was found between t-PA and plasminogen (r = 0.74, p <0.001). Lysibility by SK related to plasminogen content in both venous (r = 0.60, p <0.002) and arterial (r = 0.44, p <0.05) thrombi; PAI-1 and t-PA did not correlate with lysibility. Lysibility in the chosen concentrations of SK, UK and t-PA were similar.We conclude that spontaneous lysis of thrombi in saline is dependent on PAI-1 content and that susceptibility of thrombibi to lysis by SK ex vivo is dependent on the plasminogen contentKeywords
This publication has 13 references indexed in Scilit:
- The activity of plasminogen activator inhibitor-1 (PAI-1) of human plateletFibrinolysis, 1990
- Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivoThrombosis Research, 1990
- Protraction of whole blood and plasma clot lysis in patients with high levels of an inhibitor of tissue-type plasminogen activatorThrombosis Research, 1985
- The fibrinolytic action of flufenamate and its influence on plasminogen binding to fibrinThrombosis Research, 1985
- Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.Journal of Clinical Investigation, 1984
- Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysisEuropean Journal of Biochemistry, 1984
- Local Low-Dose Thrombolytic Therapy of Peripheral Arterial OcclusionsNew England Journal of Medicine, 1982
- A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein ThrombosisActa Medica Scandinavica, 1978
- Controlled Trial of Ancrod and Streptokinase in the Treatment of Deep Vein Thrombosis of Lower LimbBritish Journal of Haematology, 1974
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959